NTT Docomo took part in a series A round for VR technology developer Hikky that stands at $57.1m so far while cancer therapy developer Ankyra raised $45m from investors including GV.
Funding
Japan-based virtual reality technology provider Hikky reached a ¥6.5bn ($57.1m) first close of its series A round today that included mobile network operator NTT Docomo. Hikky will also collaborate with NTT Docomo and parent company NTT through a strategic partnership agreement.
US-based oncology drug developer Ankyra Therapeutics completed a $45m series B round on Friday that included GV, a corporate venturing subsidiary of internet and technology conglomerate Alphabet. Investment and financial services group Fidelity also took part in the…
